This inventor holds 8 USPTO granted patents and 7 published patent applications and 1 EPO patent. Top assignees: University of Southern California, Usc/norris Comprehensive Cancer Ctr.. Active years: 2001-2023.
Location History:
- Rowland Heights, CA (US) (2001 - 2017)
- Los Angeles, CA (US) (2020 - 2023)
Company Filing History:
7 out of 1,691 
1 out of 1 Years Active: 2001-2023
Title: Innovations in Bladder Cancer Diagnosis by Gangning Liang
Introduction
Gangning Liang is a notable inventor based in Rowland Heights, CA (US). He has made significant contributions to the field of cancer research, particularly in the diagnosis and prognosis of bladder cancer. With a total of 8 patents to his name, Liang's work is at the forefront of medical innovation.
Latest Patents
Liang's latest patents focus on DNA methylation biomarkers for bladder cancer. These patents describe a method for predicting, diagnosing, and assessing the prognosis of bladder cancer or its recurrence in patients. The method involves providing a test sample from the subject and measuring DNA methylation levels of specific polynucleotides, including HOXA9, SOX1, NPY, IRAK3, L1-MET, and ZO2. A risk score is calculated based on these measurements, which is then compared to a cut-off value derived from a reference DNA methylation profile. This comparison allows for determining whether bladder cancer has recurred, the likelihood of recurrence, or if the patient currently has bladder cancer.
Career Highlights
Throughout his career, Gangning Liang has worked with prestigious institutions, including the University of Southern California and the USC/Norris Comprehensive Cancer Center. His research has significantly advanced the understanding of bladder cancer and its biomarkers.
Collaborations
Liang has collaborated with esteemed colleagues such as Peter A. Jones and Mark L. Gonzalgo, contributing to the collective effort in cancer research and innovation.
Conclusion
Gangning Liang's work in developing DNA methylation biomarkers for bladder cancer represents a significant advancement in medical diagnostics. His contributions continue to impact the field and improve patient outcomes.